Two doses of Sinovac can stop spread of COVID-19 - National Vaccine Institute

23 Sept 01:58 Key points summarised by AI

Research by the Thai Red Cross and USAMD-AFRIMS found that 95% of individuals who received two Sinovac doses developed an immune response, with over 70% demonstrating a strong enough response to prevent SARS-CoV-2 spread in laboratory tests.
The National Vaccine Institute confirmed these findings from clinical trials involving 186 volunteers, indicating the vaccine's effectiveness in generating immunity against the virus.
The Institute cautioned that individual immune responses may vary and advised against public self-testing, emphasizing that even fully vaccinated individuals must continue protective measures against infection.
The Disease Control Department reported common, generally mild, side effects for both Sinovac and AstraZeneca vaccines, including pain/swelling at the injection site, headache, muscle pain, and fatigue, occurring within 30 minutes and 24 hours post-inoculation.

Six injured after car smashes into On Nut shopping mall

Yesterday 22:44 Key points summarised by AI

A 67-year-old woman drove her car through the glass frontage of a Bangkok shopping mall, injuring six people, including a six-year-old girl.
The driver claimed she accidentally pressed the accelerator instead of the brake after being startled, causing the vehicle to surge forward.
She apologized to the victims, promising insurance coverage and additional financial aid, while police continue to gather statements before filing charges.